{
  "report_rows": [
    {
      "kpi": "Adj. Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$11.10 vs. cons $10.75",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Wrap Net Flows - AWM (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~$5.5B vs. cons $5.86B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Annualized Organic Growth (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~1.1% vs. cons 1.29%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "AWM Margin (FY 2026)",
      "prediction": "UNKNOWN",
      "answer": "guide ~29-30% vs. cons UNKNOWN",
      "confidence": "LOW"
    },
    {
      "kpi": "G&A Growth (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide mid-single digit vs. cons $3.89B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Capital Return (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 85-90% vs. cons UNVERIFIED",
      "confidence": "HIGH"
    },
    {
      "kpi": "Organic Growth Target (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 4-5% reaffirmed vs. cons 3.83%",
      "confidence": "HIGH"
    },
    {
      "kpi": "Comerica/Huntington Timeline (Q3/Q4 2026)",
      "prediction": "UNCHANGED",
      "answer": "Comerica fully out Q3-end; Huntington Q4 on track vs. prior guidance",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE - implicit flow cut pulls estimates lower; no new catalyst to sustain the pre-run",
  "day5_confidence": "MEDIUM"
}